The specific aim of this study is to determine whether plasma hyperhomocysteinemia is a significant risk factor for thrombosis in patients with IBD. This will be accomplished by comparing the prevalence of hyperhomocysteinemia in IBD patients with a history of thrombotic events (""""""""cases"""""""") to the prevalence of hyperhomocysteinemia among matched IBD patients without thrombotic events (""""""""controls"""""""").
Showing the most recent 10 out of 945 publications